<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Elevated microsatellite alterations at selected tetranucleotide repeats (EMAST) is a genetic signature observed in 60% of <z:hpo ids='HP_0003745'>sporadic</z:hpo> <z:e sem="disease" ids="C1527249" disease_type="Neoplastic Process" abbrv="">colorectal cancers</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRCs</z:e>) </plain></SENT>
<SENT sid="1" pm="."><plain>Unlike microsatellite unstable <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRCs</z:e> where hypermethylation of the DNA mismatch repair (MMR) gene hMLH1's promoter is causal, the precise cause of EMAST is not clearly defined but points towards hMSH3 deficiency </plain></SENT>
<SENT sid="2" pm="."><plain>AIM: To examine if hMSH3 deficiency causes EMAST, and to explore mechanisms for its deficiency </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: We measured -4 bp framshifts at D8S321 and D20S82 loci within EGFP-containing constructs to determine EMAST formation in MMR-proficient, hMLH1⁻/⁻, hMSH6⁻/⁻, and hMSH3⁻/⁻ <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> cells </plain></SENT>
<SENT sid="4" pm="."><plain>We observed the subcellular location of hMSH3 with <z:mp ids='MP_0003674'>oxidative stress</z:mp> </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: D8S321 mutations occurred 31-and 40-fold higher and D20S82 mutations occurred 82-and 49-fold higher in hMLH1⁻/⁻ and hMSH3⁻/⁻ cells, respectively, than in hMSH6⁻/⁻ or MMR-proficient cells </plain></SENT>
<SENT sid="6" pm="."><plain>hMSH3 knockdown in MMR-proficient cells caused higher D8S321 mutation rates (18.14 and 11.14×10⁻⁴ mutations/cell/generation in two independent clones) than scrambled controls (0 and 0.26×10⁻⁴ mutations/cell/generation; p&lt;0.01) </plain></SENT>
<SENT sid="7" pm="."><plain>DNA sequencing confirmed the expected frameshift mutations with evidence for ongoing mutations of the constructs </plain></SENT>
<SENT sid="8" pm="."><plain>Because EMAST-positive <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> are associated with <z:mp ids='MP_0001845'>inflammation</z:mp>, we subjected MMR-proficient cells to <z:mp ids='MP_0003674'>oxidative stress</z:mp> via H₂O₂ to examine its effect on hMSH3 </plain></SENT>
<SENT sid="9" pm="."><plain>A reversible nuclear-to-cytosol shift of hMSH3 was observed upon H₂O₂ treatment </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSION: EMAST is dependent upon the MMR background, with hMSH3⁻/⁻ more prone to frameshift mutations than hMSH6⁻/⁻, opposite to frameshift mutations observed for <z:chebi fb="0" ids="29075">mononucleotide</z:chebi> repeats </plain></SENT>
<SENT sid="11" pm="."><plain>hMSH3⁻/⁻ mimics complete MMR failure (hMLH1⁻/⁻) in inducing EMAST </plain></SENT>
<SENT sid="12" pm="."><plain>Given the observed <z:hpo ids='HP_0001425'>heterogeneous</z:hpo> expression of hMSH3 in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRCs</z:e> with EMAST, hMSH3-deficiency appears to be the event that commences EMAST </plain></SENT>
<SENT sid="13" pm="."><plain><z:mp ids='MP_0003674'>Oxidative stress</z:mp>, which causes a shift of hMSH3's subcellular location, may contribute to an hMSH3 loss-of-function phenotype by sequestering it to the cytosol </plain></SENT>
</text></document>